There was a significant increase in proximal optic nerve axonal transport with AAV2 TrkB-2A-mBDNF in the tauopathy model administered after the onset of tau pathology relative to naive, AAV2 null, and AAV2 green fluorescent protein (GFP) controls (Fig. 3, C and D). The gene discussed is MAPT; the disease is tauopathy.